DIRNANO is a MSCA-ITN project (grant agreement 956544) that focuses in the development of a library of nanoparticles (NPs) with widely tunable immune-interaction qualities - stealth, long-circulating or immune cells-targeted - through understanding and controlling the mechanisms operating at the nano-host interface. The goal is to attain a comprehensive understanding of nanomaterials-host interplay to tame body’s defenses and adverse immune reactions to fully therapeutic potential of nanomedicines

We will develop strategies to map, study, modulate and exploit nanoparticle (NP)
Immune interactions

DIRNANO MSCA-ITN

Org chart

Teams

Offices

DIRNANO MSCA-ITN

Org chart

Teams

Offices

Related companies